- Home
- SRTS vs VRCA Comparison
SRTS vs VRCA Comparison
Compare SRTS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- VRCA
- Stock Information
- Founded
- SRTS 2010
- VRCA 2013
- Country
- SRTS United States
- VRCA United States
- Employees
- SRTS N/A
- VRCA N/A
- Industry
- SRTS Medical/Dental Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- VRCA Health Care
- Exchange
- SRTS Nasdaq
- VRCA Nasdaq
- Market Cap
- SRTS 77.9M
- VRCA 65.4M
- IPO Year
- SRTS 2016
- VRCA 2018
- Fundamental
- Price
- SRTS $4.16
- VRCA $0.81
- Analyst Decision
- SRTS Strong Buy
- VRCA Hold
- Analyst Count
- SRTS 3
- VRCA 5
- Target Price
- SRTS $11.67
- VRCA $6.00
- AVG Volume (30 Days)
- SRTS 56.1K
- VRCA 775.3K
- Earning Date
- SRTS 08-07-2025
- VRCA 08-13-2025
- Dividend Yield
- SRTS N/A
- VRCA N/A
- EPS Growth
- SRTS N/A
- VRCA N/A
- EPS
- SRTS 0.11
- VRCA N/A
- Revenue
- SRTS $39,488,000.00
- VRCA $7,179,000.00
- Revenue This Year
- SRTS $4.33
- VRCA $171.87
- Revenue Next Year
- SRTS $31.55
- VRCA $71.38
- P/E Ratio
- SRTS $38.07
- VRCA N/A
- Revenue Growth
- SRTS 24.75
- VRCA N/A
- 52 Week Low
- SRTS $4.01
- VRCA $0.38
- 52 Week High
- SRTS $9.33
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- SRTS 28.08
- VRCA 70.98
- Support Level
- SRTS $4.45
- VRCA $0.77
- Resistance Level
- SRTS $4.81
- VRCA $0.67
- Average True Range (ATR)
- SRTS 0.19
- VRCA 0.08
- MACD
- SRTS -0.05
- VRCA 0.03
- Stochastic Oscillator
- SRTS 0.00
- VRCA 81.85
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.